Goodman, K.W. 2003. Ethics and evidence-based medicine: Fallibility and responsibility in clinical science. Cambridge: Cambridge University Press.
Timmermans, S., and M. Berg. 2003. The gold standard: The challenge of evidence-based medicine and standardization in health care. Philadelphia: Temple University Press.
Bodenheimer, T., and K. Grumbach. 2009. Understanding health policy: A clinical approach, 5th ed. New York: McGraw-Hill.
Institute of Medicine. 2000. To err is human: Building a safer health care system. Washington, D.C.: National Academies Press.
Chassin, M.R., and J.M. Loeb. 2011. The ongoing quality improvement journey. Health Affairs
Marks, H.M. 1997. The progress of experiment: Science and therapeutic reform in the United States, 1900–1990. New York: Cambridge University Press.
Institute of Medicine. 2001. Crossing the quality chasm: A new health system for the 21st century. Washington, D.C.: National Academies Press.
Qaseem, A., V. Snow, D.K. Owens, and P. Shekelle. 2010. The development of clinical practice guidelines and guidance statements of the American College of Physicians: Summary of methods. Annals of Internal Medicine 153(3): 194–197.
Oxford Centre for Evidence-Based Medicine. 2001. Levels of evidence. www.entkent.com/html/Oxford_CEBM_Levels_5.htm
. Accessed 8/21/11.
Werner, R.M., J.T. Kolstad, E.A. Stuart, and D. Polsky. 2011. The effect of pay-for-performance in hospitals: Lessons for quality improvement. Health Affairs
Tanenbaum, S.J. 2009. Pay-for-performance in medicare: Evidentiary irony and the politics of value. Journal of Health Politics, Policy and Law
Schon, D.A. 1983. The reflective practitioner: How professionals think in action. London: Temple Smith.
Klein, G.A. 1999. Sources of power: How people make decisions. Cambridge, MA: MIT Press.
Goldenberg, M.J. 2006. On evidence and evidence-based medicine: Lessons from the philosophy of science. Social Science and Medicine
Hacking, I. 1990. The taming of chance. New York: Cambridge University Press.
Marks, H.M. 2009. What does evidence do? Histories of therapeutic research. In Harmonizing drugs: Standards in 20th century pharmaceutical history, ed. C. Bonah, C. Masutti, A. Rasmussen, et al. Paris: Editions Glyphe.
Wennberg, J.E. 2010. Tracking medicine: A researcher’s quest to understand health care. New York: Oxford University Press.
Tanenbaum, S.J. 1994. Knowing and acting in medical practice: The epistemological politics of outcomes research. Journal of Health Politics, Policy and Law
Gray, B.H., M.K. Gusmano, and S.R. Collins. 2003. AHCPR and the changing politics of health services research. Health Affairs W3: 283–307.
Moyé, L.A. 2006. Statistical reasoning in medicine: The intuitive p-value primer, 2nd ed. New York: Springer.
Goodman, S. 1999. Probability at the bedside: The knowing of chances or the chances of knowing. Annals of Internal Medicine 130(7): 604–606.
Dans, A.L., L.F. Dans, G.H. Guyatt, and S. Richardson. 1998. Users’ guides to the medical literature: XIV. How to decide on the applicability of clinical trial results to your patient. Evidence-based medicine working group. JAMA
Kravitz, R.L., N. Duan, and J. Braslow. 2004. Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages. Milbank Quarterly
Agency for Health Care Research and Quality. 2010. Comparative effectiveness review methods: Clinical heterogeneity
. Publication No. 10-EHC070-EF. http://www.effectivehealthcare.ahrq.gov/ehc/products/93/533/Clinical_Heterogeneity_Revised_Report.pdf
. Accessed 7/27/2012.
Kravitz, R.L., N. Duan, E.J. Niedzinski, M.C. Hay, S.K. Subramanian, and T.S. Weisner. 2008. What ever happened to N-of-1 trials? Insiders’ perspectives and a look to the future. Milbank Quarterly
Boyd, C., J. Darer, C. Boult, et al. 2005. Clinical practice guidelines and the quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA
Pogach, L.M.A., A. Tawari, M. Maney, et al. 2007. Should mitigating comorbidities be considered in assessing healthcare plan performance in achieving optimal glycemic control? American Journal of Managed Care 13: 133–140.
Walter, L.C., N.P. Davidowitz, P.A. Heineken, and K.E. Covinsky. 2004. Pitfalls of converting practice guidelines into quality measures: Lessons learned from a VA performance measure. JAMA
Sackett, D., R.B. Haynes, G.H. Guyatt, et al. 1991. Clinical epidemiology: A basic science of clinical medicine, 2nd ed. Boston: Little, Brown.
Brookes, S.T., L. Biddle, C. Paterson, G. Woolhead, and P. Dieppe. 2007. “Me’s me and you’s you”: Exploring patients’ perspectives of single patient (n-of-1) trial in the UK. Trials
8(10): 1–8. www.trialsjournal.com/content/8/1/10
Doran, T., C. Fullwood, H. Gravelle, D. Reeves, E. Kontopantelis, U. Hiroeh, and M. Roland. 2006. Pay-for-performance programs in family practices in the United Kingdom. New England Journal of Medicine
Angell, M. 1993. The doctor as double agent. Kennedy Institute Ethics Journal
Morone, J.A. 2011. Big ideas, broken institutions, and the wrath at the grass roots. Journal of Health Politics, Policy and Law
Avorn, J. 2009. Debate about funding comparative-effectiveness research. New England Journal of Medicine
Coelho, T. 2010. A patient advocate’s perspective on patient-centered comparative effectiveness research. Health Affairs